Develop site-centric protocols to optimize enrollment and maximize performance
In an attempt to meet regulatory expectations, clinical trials are challenged by highly complex protocol design. But these study plans…
All articles by Alexander Love
Alexander Love
-
-
Five considerations for adopting AI in clinical study build workflows
Artificial intelligence (AI) is becoming widely adopted in clinical data management, but the most persuasive use cases are rarely the…
-
Post-marketing oncology studies: Enabling faster recruitment and lower costs
Post-marketing approval studies in clinical research for cancer typically suffer from poor engagement and protracted timelines – driving up costs…
-
Peptide drug conjugates: How the Indena and Chemi partnership is delivering
The pharmaceutical industry is investing heavily in therapies capable of delivering high-potent treatments to diseased cells while limiting damage to…
-
Enhance clinical trial screening and improve patient matching accuracy
Traditional approaches to patient-trial matching often rely solely on structured data, leading to inaccurate eligibility lists and missed opportunities to…
-
How price variation impacts employers
This is the first episode in our second season exploring the evolving landscape of real-world data and its role in…
-
Quality by design: The impact of disconnected systems on clinical data
As clinical trials become more digitalised, the data landscape is expanding faster than the processes designed to control it. Electronic…
-
Podcast: The growth of clinical trials and research in Israel
Israel has a robust and growing clinical trials ecosystem. This podcast explores the factors that what make Israel such an…
-
The cost of inefficiencies in clinical trials
Clinical trials are expensive, time-sensitive, and closely monitored, with sponsors and contract research organisations (CROs) under pressure to run studies…
-
How Saudi Arabia is developing as a Middle East hub for clinical trials
Saudi Arabia is primed to emerge as the Middle East’s key hub for clinical trials, driven by both sustained state…